Synagis and Trimethoprim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synagis and Trimethoprim. Common interactions include abdominal distension among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people who take Synagis and Trimethoprim have. It is created by eHealthMe based on reports of 20 people who take Synagis and Trimethoprim from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 02, 2022

20 people who take Synagis and Trimethoprim together, and have interactions are studied.


What is Synagis?

Synagis has active ingredients of palivizumab. eHealthMe is studying from 16,714 Synagis users for its effectiveness, alternative drugs and more.

What is Trimethoprim?

Trimethoprim has active ingredients of trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 5,857 Trimethoprim users for its effectiveness, alternative drugs and more.

Number of Synagis and Trimethoprim reports submitted per year:

Synagis and Trimethoprim drug interactions.

Common Synagis and Trimethoprim drug interactions by gender *:

female:

  1. Abdominal distension
  2. Diarrhoea
  3. Pneumonitis
  4. Arrhythmia
  5. Sudden infant death syndrome
  6. Anaphylactoid reaction
  7. Central line infection
  8. Convulsions
  9. Echocardiogram abnormal
  10. Hepatic failure

male:

  1. Pyrexia
  2. Cough
  3. Heart rate increased
  4. Hypothalamo-pituitary disorder
  5. Oxygen saturation decreased
  6. Peripheral coldness
  7. Respiratory rate increased
  8. Skin discolouration
  9. Crying
  10. Injection site erythema

Common Synagis and Trimethoprim drug interactions by age *:

0-1:

  1. Hypothalamo-pituitary disorder
  2. Peripheral coldness
  3. Respiratory rate increased
  4. Skin discolouration
  5. Arrhythmia
  6. Cough
  7. Crying
  8. Dyspnoea
  9. Injection site erythema
  10. Injection site papule

2-9:

  1. Body temperature increased
  2. Excoriation
  3. Oxygen saturation decreased
  4. Viral infection

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Bronchopulmonary Dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type): 5 people, 25.00%
  2. Lung Disorder (lung disease): 2 people, 10.00%
  3. Premature Baby: 1 person, 5.00%
  4. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 5.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
  6. Cardiomyopathy (weakening of the heart muscle): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Synagis and Trimethoprim?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Synagis and Trimethoprim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Synagis side effects:

Browse all side effects of Synagis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Trimethoprim side effects:

Browse all side effects of Trimethoprim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Synagis interactions:

Browse all interactions between Synagis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Trimethoprim interactions:

Browse all interactions between Trimethoprim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on palivizumab and trimethoprim (the active ingredients of Synagis and Trimethoprim, respectively), and Synagis and Trimethoprim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Synagis and Trimethoprim.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: